These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
853 related articles for article (PubMed ID: 30915595)
1. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma. Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595 [TBL] [Abstract][Full Text] [Related]
2. Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma. Dong Z; Li S; Wu X; Niu Y; Liang X; Yang L; Guo Y; Shen S; Liang J; Guo W Cell Death Dis; 2019 Dec; 10(12):930. PubMed ID: 31804468 [TBL] [Abstract][Full Text] [Related]
3. MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression. Guo W; Liang X; Liu L; Guo Y; Shen S; Liang J; Dong Z Gastric Cancer; 2019 Jul; 22(4):705-722. PubMed ID: 30656427 [TBL] [Abstract][Full Text] [Related]
4. Methylation Mediated Downregulation of TOB1-AS1 and TOB1 Correlates with Malignant Progression and Poor Prognosis of Esophageal Squamous Cell Carcinoma. Dong Z; Zhang G; Lu J; Guo Y; Liang J; Shen S; Guo W Dig Dis Sci; 2023 Apr; 68(4):1316-1331. PubMed ID: 36002674 [TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma. Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086 [TBL] [Abstract][Full Text] [Related]
6. SEMA3B improves the survival of patients with esophageal squamous cell carcinoma by upregulating p53 and p21. Tang H; Wu Y; Liu M; Qin Y; Wang H; Wang L; Li S; Zhu H; He Z; Luo J; Wang H; Wang Q; Luo S Oncol Rep; 2016 Aug; 36(2):900-8. PubMed ID: 27349960 [TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter 2 methylation‑mediated downregulation of protein tyrosine phosphatase, non‑receptor type 6, is associated with progression of esophageal squamous cell carcinoma. Liu L; Zhang S; Liu X; Liu J Mol Med Rep; 2019 Apr; 19(4):3273-3282. PubMed ID: 30816454 [TBL] [Abstract][Full Text] [Related]
8. p53-induced long non-coding RNA PGM5-AS1 inhibits the progression of esophageal squamous cell carcinoma through regulating miR-466/PTEN axis. Zhihua Z; Weiwei W; Lihua N; Jianying Z; Jiang G IUBMB Life; 2019 Oct; 71(10):1492-1502. PubMed ID: 31185143 [TBL] [Abstract][Full Text] [Related]
9. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development. Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858 [TBL] [Abstract][Full Text] [Related]
10. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer. Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329 [TBL] [Abstract][Full Text] [Related]
11. LncRNA ZEB1-AS1 down-regulation suppresses the proliferation and invasion by inhibiting ZEB1 expression in oesophageal squamous cell carcinoma. Zhao Y; Wang N; Zhang X; Liu H; Yang S J Cell Mol Med; 2019 Dec; 23(12):8206-8218. PubMed ID: 31638344 [TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma. Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Shan B Dig Liver Dis; 2016 Aug; 48(8):961-9. PubMed ID: 27338851 [TBL] [Abstract][Full Text] [Related]
13. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis. Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665 [TBL] [Abstract][Full Text] [Related]
14. Functional Role of a Novel Long Noncoding RNA Lin C; Zhang S; Wang Y; Wang Y; Nice E; Guo C; Zhang E; Yu L; Li M; Liu C; Hu L; Hao J; Qi W; Xu H Clin Cancer Res; 2018 Jan; 24(2):486-498. PubMed ID: 29101304 [No Abstract] [Full Text] [Related]
15. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus. Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529 [TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation-mediated downregulation of long noncoding RNA C5orf66-AS1 promotes the development of gastric cardia adenocarcinoma. Guo W; Lv P; Liu S; Xu F; Guo Y; Shen S; Liang J; Kuang G; Dong Z Mol Carcinog; 2018 Jul; 57(7):854-865. PubMed ID: 29566283 [TBL] [Abstract][Full Text] [Related]
17. Expression of long non-coding RNA ZEB1-AS1 in esophageal squamous cell carcinoma and its correlation with tumor progression and patient survival. Wang YL; Bai Y; Yao WJ; Guo L; Wang ZM Int J Clin Exp Pathol; 2015; 8(9):11871-6. PubMed ID: 26617942 [TBL] [Abstract][Full Text] [Related]
18. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670 [TBL] [Abstract][Full Text] [Related]
19. MiR-718 mediates the indirect interaction between lncRNA SEMA3B-AS1 and PTEN to regulate the proliferation of hepatocellular carcinoma cells. Zhong Y; Li Y; Song T; Zhang D Physiol Genomics; 2019 Oct; 51(10):500-505. PubMed ID: 31251699 [TBL] [Abstract][Full Text] [Related]
20. lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer. Yu H; Wu Y; Huang J; Li S Anticancer Res; 2023 Dec; 43(12):5475-5484. PubMed ID: 38030196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]